ArticleTranslational lung cancer research2020
Radiomic features of primary tumor by lung cancer stage: analysis in
Article in Translational lung cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Radiomics prediction of surgery in ulcerative colitis refractory to medical treatment.Techniques in coloproctology · 2025Article
- Intelligent prognosis evaluation system for stage I-III resected non-small-cell lung cancer patients on CT images: a multi-center study.EClinicalMedicine · 2023Article
- Feature selection methods and predictive models in CT lung cancer radiomics.Journal of applied clinical medical physics · 2023Review
- Prognostic and predictive value of radiomic signature in stage I lung adenocarcinomas following complete lobectomy.Journal of translational medicine · 2022Article
- Structural and functional radiomics for lung cancer.European journal of nuclear medicine and molecular imaging · 2021Review
- Association between tumor size and peritumoral brain edema in patients with convexity and parasagittal meningiomas.PloS one · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe clinical features and traditional semantic imaging characteristics of
methodsOur IRB approved study included 62 patients with
resultsThere were significant differences in the radiomic features based on cancer stages I-IV with the most significant differences between stage IV and stage I lesions [AUC 0.94 (95% CI: 0.86-0.99), P<0.04]. There were also significant differences in radiomic features between stage IV and combined stages I-III [40/113 radiomic features; AUC 0.71 (95% CI: 0.59-0.85); P<0.04-0.0001]. None of the clinical (0/6) or imaging (0/3) features were significantly different between stage IV and combined stages I-III.
conclusionsThe radiomic features of primary tumor in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.